FDA Drug Application (022173) for ZYPREXA RELPREVV by ELI LILLY CO

Back to FDA Applications sponsored by ELI LILLY CO

Application Number022173
Product Number001
FormSUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR
DosageEQ 210MG BASE/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameZYPREXA RELPREVV
Active IngredientOLANZAPINE PAMOATE



Back to FDA Applications sponsored by ELI LILLY CO